This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB01651/identifier/pdb/
n5http://linked.opendata.cz/resource/drugbank/drug/DB01651/identifier/pubchem-compound/
n12http://bio2rdf.org/drugbank:
n6http://linked.opendata.cz/resource/drugbank/drug/DB01651/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n7http://linked.opendata.cz/resource/drugbank/drug/DB01651/identifier/drugbank/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n8http://linked.opendata.cz/ontology/drugbank/
n9http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/drugbank/drug/DB01651/identifier/chemspider/

Statements

Subject Item
n2:DB01651
rdf:type
n8:Drug
n8:group
experimental
owl:sameAs
n12:DB01651 n13:DB01651
dcterms:title
Methyl 4,6-O-[(1r)-1-Carboxyethylidene]-Beta-D-Galactopyranoside
adms:identifier
n4:11190325 n5:445936 n6:46508799 n7:DB01651 n10:CDG
n8:IUPAC-Name
n9:271B6069-363D-11E5-9242-09173F13E4C5
n8:InChI
n9:271B606F-363D-11E5-9242-09173F13E4C5
n8:Molecular-Formula
n9:271B606E-363D-11E5-9242-09173F13E4C5
n8:Molecular-Weight
n9:271B606B-363D-11E5-9242-09173F13E4C5
n8:Monoisotopic-Weight
n9:271B606C-363D-11E5-9242-09173F13E4C5
n8:SMILES
n9:271B606D-363D-11E5-9242-09173F13E4C5
n8:Water-Solubility
n9:271B6067-363D-11E5-9242-09173F13E4C5
n8:logP
n9:271B6068-363D-11E5-9242-09173F13E4C5 n9:271B6065-363D-11E5-9242-09173F13E4C5
n8:logS
n9:271B6066-363D-11E5-9242-09173F13E4C5
n8:H-Bond-Acceptor-Count
n9:271B6075-363D-11E5-9242-09173F13E4C5
n8:H-Bond-Donor-Count
n9:271B6076-363D-11E5-9242-09173F13E4C5
n8:InChIKey
n9:271B6070-363D-11E5-9242-09173F13E4C5
n8:Polar-Surface-Area--PSA-
n9:271B6071-363D-11E5-9242-09173F13E4C5
n8:Polarizability
n9:271B6073-363D-11E5-9242-09173F13E4C5
n8:Refractivity
n9:271B6072-363D-11E5-9242-09173F13E4C5
n8:Rotatable-Bond-Count
n9:271B6074-363D-11E5-9242-09173F13E4C5
n8:Bioavailability
n9:271B607B-363D-11E5-9242-09173F13E4C5
n8:Ghose-Filter
n9:271B607D-363D-11E5-9242-09173F13E4C5
n8:MDDR-Like-Rule
n9:271B607E-363D-11E5-9242-09173F13E4C5
n8:Number-of-Rings
n9:271B607A-363D-11E5-9242-09173F13E4C5
n8:Physiological-Charge
n9:271B6079-363D-11E5-9242-09173F13E4C5
n8:Rule-of-Five
n9:271B607C-363D-11E5-9242-09173F13E4C5
n8:Traditional-IUPAC-Name
n9:271B606A-363D-11E5-9242-09173F13E4C5
n8:pKa--strongest-acidic-
n9:271B6077-363D-11E5-9242-09173F13E4C5
n8:pKa--strongest-basic-
n9:271B6078-363D-11E5-9242-09173F13E4C5